相关实验视频

Updated: Jul 17, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

前列腺癌中化学抗原受体修饰T细胞疗法:关于当前状态和前景的全面审查

Mingze He¹, Dongqi Zhang², Yu Cao³

¹Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119435, Moscow, Russia.

|September 4, 2023

概括

化学抗原受体T细胞 (CAR-T) 疗法对前列腺癌 (PCa) 有希望,但在固体瘤中面临挑战. 未来的研究应该专注于新的目标和克服瘤微环境,以提高CAR-T的疗效.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

化学抗原受体修饰T细胞 (CAR-Ts) 对血液恶性瘤有效.
在包括前列腺癌 (PCa) 在内的固体瘤中应用CAR-T疗法仍然具有挑战性.
尽管面临挑战,但CAR-T免疫疗法对晚期转移性PCa提供了患者的希望.

研究的目的:

对CAR-T治疗的前列腺瘤相关抗原标进行审查.
在PCa.讨论当前CAR-T目标的临床研究状态.
探索增强固体瘤中CAR-T疗效的策略.

主要方法:

关于前列腺癌中CAR-T疗法的文献综述.
分析与瘤相关的抗原标 (例如PSMA,PSCA).
讨论多模式免疫疗法,化疗和联合CAR-T方法.

主要成果:

确定了像PSMA和PSCA这样的关键前列腺瘤相关抗原.
评估了针对这些抗原的CAR-T疗法的临床进展.
详细阐述了固体瘤治疗中的障碍,包括异质性和免疫抑制.

结论:

卡特-T疗法具有PCa的潜力,但需要克服固体瘤障碍.
新的目标发现和组合策略对于提高CAR-T疗效至关重要.
解决瘤异质性和免疫抑制微环境对于未来的成功至关重要.

关键词:

在CAR-T中,我们可以使用CAR-T.免疫治疗是一种免疫疗法.前列腺癌是什么意思前列腺癌是什么意思固体瘤是一个固体瘤.瘤微环境是一个微环境.与瘤相关的抗原.

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...